findmyKOL

Paul Kwo, MD

Enriched profile

Professor of Medicine (Gastroenterology and Hepatology) · Stanford University School of Medicine

ORCIDNPI
Region🇺🇸 Stanford, CA · West · United StatesSpecialtyGastroenterologyFocusGastroenterology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNone verifiedPayments2021–2025NIH fundingNone on fileWhy? →

Paul Kwo is Professor of Medicine (Gastroenterology and Hepatology) at Stanford University School of Medicine. OpenAlex indexes 473 publications with 21,210 citations (h-index 67); ClinicalTrials.gov lists 2 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Gastroenterology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Paul Y. Kwo, MD, is Professor of Medicine (Gastroenterology and Hepatology) at Stanford University School of Medicine. The public record shows 473 publications with 21,210 citations (h-index 67), centered on Gastroenterology. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 12 companies.

  • Most recent indexed publication: 2026 · Liver transplantation
  • Top research focus: Gastroenterology
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 12 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Hepatic Insufficiency1 trial

Research focus

OpenAlex concept fingerprint
Gastroenterology

Drugs & molecules

across trials, industry payments and publications
Vemlidygeneric · Tenofovir alafenamideClinical trialsIndustry payments8PublicationsEpclusageneric · Sofosbuvir / velpatasvirClinical trialsIndustry payments7PublicationsXIFAXANgeneric · RifaximinClinical trialsIndustry payments3Publications

Works with

trial sponsors and companies reporting payments
Gilead Sciences, Inc.Clinical trialsIndustry payments34Novo Nordisk IncClinical trialsIndustry payments16Mallinckrodt Hospital Products Inc.Clinical trialsIndustry payments4

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
473publications

Distinct works indexed by OpenAlex, matched via ORCID; 16 in PubMed.

21,210citations

Total citations across indexed works.

67h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials
12companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

12 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    37.3%
    Proton pump inhibitor12.8%
    Pantoprazole Sodium42%Lansoprazole26%Omeprazole19%Esomeprazole Magnesium13%
    Part D<11 patients
    Bile Acid10.1%
    Ursodiol100%
    Part D14 patients
  • Cardiovascular

    21.6%
    Beta blocker9%
    Carvedilol100%
    Part D17 patients
    Aldosterone antagonist (MRA)5.7%
    Spironolactone100%
    Part D15 patients
  • Anti-infectives

    19.3%
    Nucleoside and nucleotide reverse transcriptase inhibitors10.7%
    Vemlidy82%Tenofovir Disoproxil Fumarate18%
    Part D<11 patients
    Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor8.6%
    Entecavir100%
    Part D12 patients
3 more therapeutic areas behind the reveal.Reveal →
Where care is delivered (Part B)29.9% facility · 70.1% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Other

    gastrogirl.com/podcast/alarming-spike-in-alcoholic-liver-disease

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →gastrogirl.com
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com
  • LinkedIn

    LinkedIn: Professor at Stanford University School of Medicine, Director of Hepatology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com
2 more mentions behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Board Certified

    American Board of Internal Medicine - Transplant Hepatology

    2006
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.stanford.edu
  • Fellowship

    Mayo Clinic Graduate Medical Education

    1995
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.stanford.edu
  • Board Certified

    American Board of Internal Medicine - Gastroenterology

    1995
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.stanford.edu
  • Residency

    University of Maryland Medical Center

    1991
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.stanford.edu
  • MD

    Wayne State University School of Medicine

    1988
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.stanford.edu

Editorial & leadership roles

journal and society appointments
  • Board of Trustees

    American College of Gastroenterology

    2021
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.stanford.edu
  • Development Committee

    American Association for the Study of Liver Diseases

    2015
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.stanford.edu
  • Editorial Board

    Journal of Clinical Gastroenterology

    2013
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.stanford.edu
1 more role behind the reveal.Reveal →

Awards & honors

honors on the public record
3 more awards behind the reveal.Reveal →

Secondary affiliations

appointments beyond the home institution
  • Liver Clinic Chief

    Digestive Health, Stanford Health Care

    2018
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.stanford.edu
  • Director of Hepatology

    Stanford University

    2016
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.stanford.edu

Media & interviews

press, podcasts and appearances
3 more media items behind the reveal.Reveal →

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.